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The antibody response of Macaca fascicularis in parotid saliva and serum to local immunization by two routes with Streptococcus mutans was studied and compared over 1 year. Antibodies were titrated and classified by indirect immunofluorescent staining using specific antiglobulin conjugates. Antiglucosyltransferase activity was assayed by an enzyme inhibition test. Animals were immunized first by injecting formalin-killed bacterial cells and cell products subcutaneously into the vicinity of the four major salivary glands. The monkeys were next immunized by retrograde instillation of antigen into the parotid duct. Extensive subcutaneous local immunization gave a serum response only. After parotid duct immunization, high titers of immunoglobulin A (IgA) antibody, along with traces of immunoglobulin G (IgG) and immunoglobulin M (IgM) antibody, appeared in the parotid saliva, and in the serum high titers of IgG antibody were present along with lower titers of IgA and IgM. IgA antibodies in parotid fluid were shown by double immunofluorescent staining to be associated with antigenic determinants which cross-reacted with an antiserum directed to human secretory component. Titers in parotid fluids and sera fell sharply when immunization was stopped. This response pattern was reproducible. High concentrations of antibody capable of inhibiting glucosyltransferase prepared from S. mutans were found in the sera, but relatively little was detected in the parotid fluids. Extensive immunization via the parotid duct resulted in transient functional impairment of the gland, as evidenced by diminished salivary flow rates. We conclude that parotid ductal immunization can be an effective method for stimulating a salivary secretory IgA antibacterial antibody response.
The establishment of dental caries as an infectious transmissible disease by Keyes (20) and the identification of Streptococcus mutans as an etiological agent of caries (10) generated renewed interest in the potential role of immunization in caries prevention. Several studies were designed to examine this role, using bacterial cells or (27) . In contrast, Wagner (Bacteriol. Proc. 67:99) found that rats immunized with live Streptococcus faecalis developed less caries than nonimmunized control animals. Hayashi et al. (19) vaccinated rodents with glucosyltransferases and glycosidic hydrolases and reported protection against dental caries. Guggenheim et al. (18) , however, reported that immunization of rats with a glucosyltransferase preparation resulted in no reduction in caries. Tanzer et al. (28) reported variable results in their attempts to immunize rats against S. mutans-induced caries.
These inconsistencies were partly the consequence of variations in experimental design. A source of confusion which did not become evident until the pioneering work of Tomasi et al. (32) (15, 29) in rabbits and of Ogra and Karzon (26) in humans that local application of antigen may induce IgA antibodies in secretions, and that parenteral administration will generally induce serum antibodies in the absence of secretory antibodies. The difference in rate of appearance and disappearance of secretory antibodies as compared to serum antibodies is well documented (25) .
The foregoing considerations underline the importance of monitoring salivary antibody production throughout the course of experiments designed to define the role of immunization in caries prevention. Taubman (11) and was shown to be cariogenic in pathogen-free rodents. S. mutans strains GS-5, BHT, and FA-1 were provided by Robert Fitzgerald, Veterans Administration Hospital, Miami, Fla., and Ronald Gibbons, Forsyth Dental Center, Boston, Mass. Organisms were grown for 36 h at 37 C in Trypticase soy broth, and the cells were harvested by centrifugation, washed three times with phosphate-buffered saline (PBS; 0.15 M NaCl, 0.02 M sodium phosphate, pH 7.4), and finally suspended in PBS containing 0.6% formalin. After 24 h at 4 C, the killed cells were washed three more times in PBS, suspended in 0.2% formalin in PBS at a concentration of 109 organisms/ml (based on McFarland standards), and stored at 4 C. Such cells were used both for vaccination and for the immunofluroescent antibody assay.
Crude glucosyltransferase preparations (CEP) were derived from culture supernatant of S. mutans strains 6715, GS-5, and BHT. Crystalline (NHJ2SO4 was dissolved in the supernatant to a final concentration of 2.4 M (35). The precipitate was recovered by centrifugation, dissolved in distilled water, dialyzed against multiple changes of distilled water, lyophilized, and stored at -20 C. The presence of glucosyltransferase in this preparation was evidenced by incorporation of the ["4C]glucose moiety of sucrose into ethanol-insoluble polysaccharide (9) . This activity remained stable for up to 2 years.
Immunization. The eight monkeys were divided into two comparable groups according to dental age. The schedule for immunization is shown in Fig. 2 . Four monkeys (group I) were injected in the vicinity of the four major salivary glands 10 times during a 35-day period. The vaccine was prepared by washing the formalinized S. mutans 6715 cells three times with PBS and suspending these at 109 cells/ml in a solution of 45 mg of CEP per ml from strain 6715 dissolved in 0.01 M sodium citrate-sodium phosphate buffer, pH 5.0. One-half milliliter of this vaccine was injected through a 27-gauge needle in multiple sites in the INFECT. IMMUN.
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Intraductal immunization was subsequently carried out on the parotid glands of the animals in group I using the same vaccine. This route was suggested by the work of McDowell and Lascelles (22) in which IgA antibody was found in the whey of sheep after ductal infusion into the mammary gland of Salmonella flagellar antigens. Glass micropipettes (Microcaps, Drummond Scientific Co., Broomall, Pa.) of various sizes (10 to 20 gl) were fire polished and fitted to polyethylene tubing 5 cm in length. Retrograde instillation of vaccine into the parotid duct (PD) was carried out using these cannula assemblies. The glass cannula was inserted into the duct, 1 ml of air was withdrawn from the ductal tree, and a stopcock fitted between the cannula assembly and syringe was closed. A syringe containing the vaccine was then fitted to the stopcock. The valve was opened, and 1.0 ml of the vaccine was slowly infused into the gland. The vaccine was delivered to both parotid glands of monkeys in group I, and an equivalent volume of citrate-phosphate buffer was infused into the parotid glands of group II. The entire dead space of the delivery system was less than 0.1 ml.
Prior to immunization a pilot study was performed to examine the mechanics of this technique. One milliliter of radioopaque medium (Hypaque, Winthrop Laboratories, New York, N.Y.) was instilled into the parotid gland of an irus monkey using the cannula and catheter assembly described above. Radiographs ( Fig. 1) were taken before, immediately after, 1 min, and 5 min after instillation of the fluid medium. The catheter was left in place in the duct, and during 30 min we witnessed no escape of fluid from the gland either around or via the catheter. The radiographs revealed nearly complete filling of the gland with the 1.0 ml of medium and progressive diffusion of material into the periphery with a concomitant decrease in radioopacity over 5 min. The filling pattem appeared normal, and little resistance was perceived to the instillation of the fluid.
Oral infection with S. mutans. All monkeys were infected with S. mutans 6715 on days 241, 248, and 278 using a technique described elsewhere (8) . This FIG. 1. Composite radiograph of a monkey parotid gland. P, Prior to instillation into the PD of 1.0 ml of radioopaque medium; 0, immediately after injection of the medium. The stopcock in PD cannula was then closed for 1 min, after which the radiograph labeled "1" was taken; "5" was taken 5 min after the opening of the stopcock. (9) . To test the inhibiting capacity of serum or saliva samples of small volume or low antibody concentration, it was necessary to reduce the volumes previously reported for the glucosyltransferase assay. The modification which we used in these experiments consisted of a 10-fold reduction in final volume to 20 Ml which contained about 37 Mg of CEP. An increase in the incubation time from 2 to 6 h was included to increase the sensitivity of the assay. These modifications have allowed us to test saliva using 10-Al samples with about a 10-fold increase in sensitivity over that obtained by the reported method (9) . Serum and saliva from monkeys immunized with S. mutans were tested for their capacity to inhibit glucosyltransferase by incubating various dilutions of the antibody source with the enzyme for 30 min at 30 C prior to the addition of the radioactive substrate and dextran primer. The procedure for determination of glucosyltransferase activity was then followed. The inhibiting capacity of the immune fluids was expressed as the percentage of reduction in radioactivity incorporated compared to control fluids from sham-immunized animals at the same dilution. Enzymes prepared from S. mutans GS-5 and BHT were tested to determine the extent of cross-reaction of the inhibiting antibody.
Detection of secretory component. Rabbit antiserum to human secretory component was prepared by immunization with human salivary IgA purified by gel filtration, anion exchange chromatography, and sucrose density gradient ultracentrifugation. The antiserum, which reacted only with IgA, was absorbed with the whole plasma from a patient with an IgA myeloma. The absorbed antiserum precipitated In a four-step staining procedure, PF containing IgA antibodies was first applied to a 6715 smear. The rabbit antiserum to human secretory component was then applied and followed by goat anti-rabbit IgG conjugated with rhodamine. In the fourth step, the fluorescein-conjugated antiserum to human IgA was applied. In parotid fluid samples containing only IgA antibody, red staining indicated the presence of secretory component and staining with both fluorochromes showed the association of secretory component with IgA antibody. Preimmune PFs, normal rabbit serum, and a non-cross-reacting strain of S. mutans were used as controls. immunoglobulin M (IgM) antibody titer was elevated, and IgG and IgA antibody was also detected (Fig. 2) . No antibody could be detected in 20 x -concentrated PF from any of the monkeys.
Immunization via the PDs. The same vaccine was then delivered to the gland by instillation into the PD. PF was collected from each animal 7 days after the first PD immunization. Two milliliters was concentrated about 20x using a Minicon apparatus (Amicon Corp., Lexington, Mass.) and assayed for antibody. IgA antibody to S. mutans 6715 was found in the concentrated PFs of three of the four animals in group I, whereas no antibody was detectable in concentrated fluids from group II animals. All succeeding antibody assays were performed on unconcentrated samples. Further PD immunization resulted in increases in the mean PF IgA antibody titer to peak at 13.5. On day 225 (Fig. 2) individual titers in the four 4 One monkey, previously unexposed to the vaccine by any route, was immunized by instillation of the vaccine into the right PD while the left duct was instilled with diluent buffer. The response pattern (Fig. 3) was similar to that seen in the above group of animals. IgA antibody was detected only in the secretions from the immunized gland, except in one sample from the left gland taken on day 265 in which it was detected at a titer of 1 initial group of monkeys, titers rose quickly after the beginning of a series of PD instillations and fell soon after immunization was stopped. Again IgA-IgG antibody titer ratios were always greater than unity in PF and less than one in the serum.
The association of secretory component with PF IgA antibody was shown by staining with the anti-human secretory component antiserum alone and by double staining with both the anti-human secretory component and antihuman IgA together. Preimmune PF showed no staining, and substitution of normal rabbit serum for the anti-human secretory component serum resulted in no staining with the goat anti-rabbit IgG. Immune PF applied to the non-cross-reacting strain of S. mutans resulted in no staining. Substitution of goat anti-human IgG for anti-human IgA in the final step resulted in red staining only, signifying the presence of secretory component and the lack of significant cross-reaction of the anti-human IgG antiserum with rabbit IgG. (Fig. 4) 175 and 200 were concentrated 16x and tested for enzyme inhibition, the mean percentage of inhibitions found were 4 and 42%, respectively. After the last series of PD injections, while the serum and PF responses were at their peak, inhibiting activity was slightly elevated but still at low levels in PF. Sera collected from immune animals at the peak of mean percentage of inhibition (day 195) of 6715 enzyme were found to inhibit enzyme preparations from BHT or GS-5 either poorly or not at all.
PF flow rates were measured as an indicator of gland function during immunization. Flow rates were recorded over a 10-min interval during peak flow beginning 2 to 5 min after administration of pilocarpine. Most often secretions from both glands were collected by two cannulas, but occasionally only one gland could be sampled. All individual flow rates were normalized to milliliters per minute per gland, and group means were calculated for each interval. The sham-immunized monkeys showed little change (Table 1) in flow rate over the experimental period, whereas the flow in the immunized animals temporarily decreased after immunization. Significant differences in flow rates between the groups were not seen until days 425 and 442 after the beginning of the last series of immunizations. Flow rates in the immune animals appeared to be recovering on day 464, when the last samples were collected.
DISCUSSION
Studies in the rabbit (29) and rat (30) showed that antibacterial antibodies could be regularly induced in the saliva by s.c. injection of bacterial components or whole cells in the vicinity of the major salivary glands. Using the same method of immunization and a similar vaccine, we were unable to elicit salivary antibody in irus monkeys; however, serum antibodies were detected. We were able to demonstrate the induction and restimulation of salivary antibacterial antibodies by intraductal instillation of vaccine into the PD. These data provide the first evidence for the induction of a secretory IgA antibacterial antibody response in primate saliva.
Indirect IFS using conjugates specific for a single immunoglobulin class permitted titration and classification of antibodies in a single procedure. Indirect IFS has been compared with indirect hemagglutination in the detection of antibodies to Plasmodium falciparum in the sera of Aotus monkeys (4 IgA antibodies to strain 6715 were detected in 20 x -concentrated PF after only 1 week, during which the monkeys received two PD immunizations. IgA antibody titers were first seen in unconcentrated PF in samples taken from two of the four monkeys 32 days after initial PD instillation similar to the finding in the one PD-immunized monkey. However, samples had not been obtained since day 7 after initial PD instillation. We predicted a significant delay in the early IgA antibody response to intraductal instillation in the monkeys already immunized by s.c. injection. We (7) have shown that the early IgA antibody-forming cell response to local immunization with dinitrophenylated bovine serum albumin in rabbits was inhibited by prior feeding or intraperitoneal injection of the same antigen. The differences in immunization schedules and sampling intervals between the four s. Several observations lead to the conclusion the IgA antibody found in the PF was synthesized in cells within the salivary glands. In the PF, IgA antibody titers were always higher than IgG. In the serum the reverse was true. These observations are inconsistent with simple transudation of serum antibodies. Immunization into a single parotid gland of an unsensitized monkey (Fig. 3 ) resulted in high titers of IgA antibodies in the secretions from that gland but only a late, barely detectable IgA response in the fluid from the contralateral control gland. Finally, secretory component was shown to be associated with the IgA antibodies in the PF. Though polymeric IgA and secretory component have been found in the serums of most species, this polypeptide chain is most commonly associated with the secretory IgA dimer, which combines with it after secretion of the dimer from the plasma cell and prior to its addition to the external secretions.
Recent observations suggest the presence of secretory IgA anamnesis (16) and particularly an anamnestic salivary IgA response (30) . Our observations agree with those (1, 23, 38) who have concluded that the IgA system shows little or no evidence of immunological memory. Little or no memory would imply the necessity for a relatively continuous supply of antigen to maintain those levels of antibody necessary for effective in vivo function. We were able to elecit secretory antibodies as long as we continued to immunize the parotid glands via the duct but antibody levels dropped quickly when the vaccine was withheld, even though the oral cavity had been infected by the immunizing strain. (17) , it may not require high concentrations of salivary antibody to tip the balance away from implantation.
In view of our findings, it is safe to speculate that an immune response can be elicited in minor salivary glands by retrograde instillation. It is suggested that application of high concentrations of antigen to the mucosa overlying these glands might elevate salivary antibodies to the level necessary to inhibit adherence of cariogenic bacteria. Concentrations of these bacteria in dental plaque would be limited by salivary antibody below the level necessary to produce dental caries. The small numbers of organisms which persist in the plaque would provide continuous stimulation, both locally of the glands and of the gut-associated lymphoid tissue. It is suggested that maintenance of this balance between antigenic stimulation and bacterial elemination would result in significant reduction in dental caries.
Levels of serum antibody capable of inhibiting glucosyltransferase were more closely correlated with serum IgG antibody titers, as measured by indirect IFS, than with serum IgA or IgM antibody. It appeared, therefore, that most of the inhibiting activity in the serum was present in the IgG class. Results with enzyme preparations from S. mutans strains GS-5 and BHT, belonging to serogroups c and b, respectively, showed little cross-inhibition. Antigenic differences between enzyme preparations from (21, 23) . The affinity of the enzyme for these polysaccharide antigens may result in their association in solution as well as on the surface of the bacterial cell. Enzymes prepared from culture supernatants for use in immunization or in the inhibition assay might be combined with these polysaccharides, permitting inhibition by antibodies directed to the group-specific antigens. This would provide one explanation for the antigenic distinctness of these enzymes exhibited by the inhibition assay. Low levels of inhibiting activity were also found in the PF but always in the presence of both IgG and IgA antibody to 6715. Most IgG antibody was assumed to be transuded from the serum and not locally synthesized.
Significant differences in average mean flow between immune and control groups were only seen during the last series of PD immunizations. The contents of the vaccine were not well defined and some may have been toxic. When the vaccine was introduced via the ducts into an animal with high titers of serum antibody, it was likely that an immunopathological reaction might interfere with secretory function. Experiments are presently being carried out to determine the mechanism of this dysfunction. Vaccines prepared from purified S. mutans antigens are being evaluated for their immunogenicity when introduced via the PD route. Immunization with these vaccines may not result in similar functional alterations.
Instillation of antigen via the PD is a relatively simple procedure. A similar technique is used in humans to obtain diagnostic radiographs of the salivary glands and is most often quick and painless. However, the practicality of this method as a mode of mass human immunization is admittedly questionable.
We have demonstrated the feasibility of inducing secretory salivary IgA antibodies in monkeys to a common human oral pathogen.
We have examined some of the characteristics of the immune response and some of the properties of the antibody. In a succeeding manuscript we will evaluate the capacity of this antibody to alter the ability of the immunizing organism to colonize the surfaces of teeth. Inhibition of bacterial colonization of smooth surfaces would suggest the use of immunization in the prevention of dental disease.
